Deferred Tax Assets, Net of Valuation Allowance of Lexaria Bioscience Corp. from 31 Aug 2016 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Lexaria Bioscience Corp. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Aug 2016 to 31 Aug 2025.
  • Lexaria Bioscience Corp. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Aug 2025 was $0.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Lexaria Bioscience Corp. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q3 2024 $0 $0 31 Aug 2024 10-K 28 Nov 2025 2025 FY
Q3 2023 $0 $0 31 Aug 2023 10-K 26 Nov 2024 2024 FY
Q3 2022 $0 31 Aug 2022 10-K 20 Nov 2023 2023 FY
Q3 2018 $0 $0 31 Aug 2018 10-K 14 Nov 2018 2018 FY
Q3 2017 $0 $0 31 Aug 2017 10-K 14 Nov 2018 2018 FY
Q3 2016 $0 31 Aug 2016 10-K 14 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.